Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of generic alfuzosin hydrochloride 10 mg prolonged-release vs Xatral XL 10 mg in healthy Thai male volunteers under fasting conditions
TCTR20230713004Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of alfuzosin in benign prostatic hyperplasia (BPH) (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
alfuzosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on TCTR20230713004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230713004.